[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.130.145. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 302
Citations 0
News From the Food and Drug Administration
July 21, 2015

Soft Tissue Filler Alert

JAMA. 2015;314(3):217. doi:10.1001/jama.2015.8139

The FDA has alerted health professionals of rare but serious injuries that may result from unintentionally injecting soft tissue fillers into facial blood vessels.

Soft tissue fillers—also called dermal fillers, injectable facial implants, or wrinkle fillers—are approved to reduce the appearance of wrinkles or to augment lips or cheeks. They’re injected directly into the treatment area. Unintentional injection into a blood vessel can block the vessel and restrict the blood supply to tissues. Embolization may result, potentially causing vision impairment, blindness, stroke, and damage to or necrosis of the skin and underlying facial structures (http://1.usa.gov/1J5fzyX).

First Page Preview View Large
First page PDF preview
First page PDF preview
×